"Characterizing petroleum as it is found in the environment as Total Petroleum Hydrocarbons (TPH) can take on a variety of meanings depending on the method used and how the TPH result is derived. Petroleum hydrocarbons comprise a vast array of chemical constituents and encompass several compounds classes, volatility ranges, and risk levels; many of which require specific detection and quantification techniques. Matching that complexity is the numerous ways in which TPH might be expressed, carrying designations such as: GRO, DRO, EPH, HEM, EPH, and/or VPH.

With a wide variety of analytical options available, covering the numerous classifications, it falls to the end user to determine which flavor is right for their particular project and which analytical solution will work best.

In this presentation we attempt to shift through the array of acronyms, methodologies, and TPH categories to provide the end users with a clearer definition of what TPH is, how it is defined, how it is measured and quantified, and provide insight into the complexities of characterizing petroleum releases as they relate to the environmental sample analysis."

"Downward reimbursement pressure and a need for cash is leading to the sale of hospital outreach programs. This is a short-term solution that provides the health system with an infusion of cash but takes away the long-term benefits and revenue potential that comes from investing in the laboratory. With proper planning, it is possible to reclaim outreach business that has been sold, as demonstrated by Tucson Medical Center."

"After this presentation, participants will be able to:

* Identify the economic pressures on hospital outreach
* Discuss the value of laboratory outreach
* List the components of a successful outreach program
* Describe the steps to reclaiming an outreach program that has been sold"

"When a healthcare organization’s technology fails, it doesn’t just disrupt operations: it hinders the delivery of optimal patient care. This session will outline the connectivity and cybersecurity technologies whose seamless operation is essential for today’s healthcare organizations, whether delivering on-site care or telehealth sessions. Understand why these technologies can help improve patient care, boost employee satisfaction and retention, and increase operational efficiency. And learn why essential to any technology strategy is a managed service partner committed to monitoring infrastructure and proactively identifying—and addressing—any issues before they affect your community’s health or data security."

"The COVID-19 crisis accelerated the digital transformation of healthcare delivery and the adoption of telehealth services. It also increased the need for innovative processes and redesigned workflows. Telehealth platforms offer more and more services to physicians and patients: triage, remote monitoring, clinical alerts, among many more. Facing the challenges of accessing and exchanging vital data from a growing number of systems, devices, facilities, and organizations, interoperability is more than ever a critical factor for successful telehealth delivery. Functionalities, specifications, requirements, clinical workflow: health and IT professionals need to work in close collaboration to bridge the gap between the clinical and technical aspects of telehealth. Sharing real-world experiences and best practices, this Digital Dialogue convenes health, information and technology experts to discuss the benefits and importance of interoperability in delivering effective and engaging telehealth services - for clinicians and patients alike."

"Centrifugation is an indispensable laboratory application for separating and purifying a range of biological materials. Although a cornerstone, gaps in general understanding of Good Laboratory Practices (21 CFR part 58) are not uncommon, and can serve to impede efficiencies, negatively impact research goals and can even increase laboratory safety risk factors. This webinar will address potential gaps, review proper use and maintenance of centrifuges, rotors, and labware with a focus on BioSafety (42 CFR part 73). The intent is to provide information to assist with utilizing centrifugation in a more productive and safe manner."

"High-dimensional flow cytometry generates a wealth of data. Computational approaches can help to simplify the complexity of large datasets; however these methods must be carefully optimized, and it is imperative that the original data be controlled for quality to avoid bias in the results. During this webinar, we will discuss potential pitfalls encountered during computational analysis of high-dimensional flow cytometry and provide possible solutions. This webinar is directed to those users with basic to medium experience in flow cytometry who may be approaching computational tools for the first time."

"Scientists are the life-blood of new product development and innovation. But in the hope of uncovering key learnings, they often spend much of their time pulling together data to conduct analysis, limiting their ability to make progress in other areas.

Uncountable makes software that enables today’s R&D leaders to implement tools that make this learning process faster, easier and more efficient. By using better quality data tools that save money and enable larger amounts of information to be processed, scientists can play to their strengths, automate time-consuming tasks and focus instead on development. The result is an improved workflow, allowing more flexible knowledge management.

This one hour webinar will focus on the benefits of implementing a true data infrastructure and the challenges that organisations often face throughout this constantly evolving journey. Will Tashman will compare traditional data collection approaches – using lab notebooks, LIMS systems and more – with new ways of maintaining structured data sets. There will also be a brief demonstration of the Uncountable system."

"The recent publication by the University of Washington (UW) in the scientific journal Science was a major breakthrough in understanding the challenges wild-run salmon face. Every Spring and Fall, millions of Salmon voyage back into their native rivers and streams to spawn. Unfortunately, significant numbers of Coho Salmon never make it to the spawning grounds.

The breakthrough at UW was identifying the acutely toxic compound to the Salmon: 6PPD-quinone. The compound, 6PPD, starts as a tire additive designed to prevent tires from breaking down and aides in meeting federal safety guidelines. These important compounds are known as antidegradants and can protect tires from anything from sunlight to oxygen to extreme temperatures. In the very process of protecting tires from oxidation, 6PPD is transformed into 6PPD-quinone, which was unknowingly toxic to Coho Salmon. As tires wear, the worn rubber is continuously deposited on roadways. This deposited material invariably makes its way into waterways through runoff from rains. Although rain naturally dilutes the runoff, the 6PPD-quinone was found to be toxic at the low concentrations found within streams and rivers.

It is still unknown how widespread this compound is in the environment, but Eurofins maintains advanced instrumentation to be able to confirm with absolute certainty the presence of 6PPD-quinone. This webinar will discuss the emerging contaminant 6PPD-quinone and the means to quantitate it in environmental samples."

"Provider silos of the previous decades are giving way to integrated health networks where various providers serve single and sometimes multiple entities. As independent laboratories, hospitals, and health systems enhance their network of providers—including numerous clinical laboratory and anatomic pathology practice partners, or M&A activities—directors and managers must embrace moving from a disjointed data infrastructure system to value-added connectivity.

Connecting multiple order sources, such as physician EMRs or other laboratories and their LIS, into a laboratory network has become a new operational imperative. The core of this call to action is better test routing and sharing and, even more importantly, accelerating clean lab service orders from all order sources. This aims to improve turnaround time, especially in STAT and other urgent situations, improve physician and patient satisfaction, and ensure timely reimbursement for testing.

Where traditional clinical laboratory operations fall short of these types of advanced connectivity goals, the effects are profound, ranging from delays in patient testing on the front end to rejected claims for reimbursement on the back end.

During the free October 6 webinar, Accelerating Lab Order Connectivity for Measurable ROI: Support for Multi-Lab Networks, hosted by Dark Daily and sponsored by Sunquest, will explain the current landscape and growth of clinical laboratory testing networks and what it means for clinical, anatomic, specialized and esoteric testing."

"Join us for a comprehensive review and discussion of the basic fundamentals of weighing and moisture determination, including the influence various external factors can have on accuracy and reproducibility of results.

As part of the discussion, we will review the importance of calibration and qualification of balances and how to meet the requirements needed to weigh in regulated environments - such as GLP/ GMP and USP Chapter 41. When it comes to optimizing moisture analysis, we will analyze the importance of sample preparation and reveal tips and tricks for achieving the best results for a variety of sample types."

"Organizations, across all scientific industries, are assessing their digital transformation journey to try and map out the key strategies to achieving a fully digitally enabled laboratory. The key to creating and implementing a digital strategy is determining where efficiencies can be made and where technologies can provide a competitive edge.

Laboratory automation provides the time and space for laboratories to focus on innovations and improvements to support real-time results, which is crucial to their overall success. Automated science – through digital solutions, lab automation, and artificial intelligence - is critical to accelerating laboratory productivity and unlocking innovation.

In this webinar, Trish Meek, Director of Marketing at Thermo Fisher Scientific, will look at driving digital transformation by leveraging automation in the lab."

"To help pathologists and pathology practice administrators with their key strategy related questions for adopting digital pathology, a new Dark Daily webinar, scheduled for Thursday, October 7, 2021, at 1 p.m. Eastern, will feature innovative healthcare industry leaders discussing how they made their decisions to adopt digital pathology across key functional areas: primary diagnosis, education, and research.

Registration is free. The webinar will be moderated by Lisa-Jean Clifford, COO and Chief Strategy Officer for Gestalt Diagnostics. Each panelist will share their experience and unique perspective in adopting digital pathology. The live event will include an interactive Q&A session with the experts and cover topics such as using digital pathology in primary diagnosis, their plans for integrating artificial intelligence (AI), serving multiple site locations, and creative ways to leverage digital pathology in support of other areas of operation.

This new 60-minute webinar, hosted by Dark Daily, will provide essential information for anatomic pathologists and pathology practice leaders who are on the verge of evolving their clinical, research and/or educational practices with digital pathology, with both short- and long-term strategies."

"As healthcare organizations ramp up on technology innovations to improve patient care and patient safety in the New Normal, cybersecurity continues to be one of the top concerns shared by IT decision makers and c-level executives, especially given limited budgets. But while most organizations invest millions in protecting laptops, servers, and data centers, they often overlook the importance in securing other critical parts of their IT infrastructure.

Please join Justine Bone, CEO of MedSec, and Michael Howard, Head of Security Practice & Analytics at HP, for an informative session on the current threat landscape and how healthcare organizations can prioritize and respond to the ever-evolving cybersecurity threats in these challenging times. In this session, we’ll go over the importance of best of breed cyber-resilience from all endpoint considerations, including PCs, printers, and medical devices, and provide practical insights on how healthcare organizations can keep their data safe from security breaches."

"The cannabis oil market continues to grow at a rapid pace, as many operators are investigating new and improved vehicles for cannabis consumption. Creating high quality cannabis oils that stand out in this expanding market requires great attention to detail; choosing the right equipment for extraction and purification, and closely monitoring cannabinoid content throughout the purification and formulation process, are essential components to ensuring elevated product quality and integrity. Further, characterizing extraction efficiencies, monitoring purification accuracy, and verifying concentration targets for derived products empowers companies to maximize their time and profits.

In this session, Waters Corporation and Thar Process will share insights regarding the best analytical tools for cannabinoid characterization and how they are implemented in a premium cannabis extraction facility."

"SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization of biologics. A suite of five built-in workflows, optimized for CID and EAD data, offers powerful and intuitive automated data processing for intact mass and peptide mapping. Powered by Genedata’s pioneering algorithms and visualization tools, users can easily investigate the identity and purity of their biologics with deeper insights on PTM, N- and O-glycosylation, disulfide bonds as well as calculate antibody drug conjugate (ADC) ratios. In addition, the transparency at each data processing step, a unique capability of Biologics Explorer, empowers biotherapeutics scientists in taking fast evidence-based decisions during biologics development and production. In this webinar, we will introduce the Biologics Explorer software and its prepackaged workflows. In addition, participants will be introduced to the “Review” data capabilities within Biologics Explorer, where a user can accept or reject a peptide based on the quality of the annotated MS and MS/MS spectra."

"This presentation describes the challenges of unintended consequences of healthcare technology. Topics highlighted include patient safety, system design, workload issues, workarounds, technology barriers, sociotechnical impact, documentation burden, and cognitive load. The role of nursing informatics with unintended consequences is emphasized."

"Today, health information exchange architectures, application interfaces and standards enable data to be accessed and shared appropriately and securely across the entire spectrum of care, within all applicable settings and with all relevant stakeholders, including the patient. During this session, health and IT experts will discuss the level of interoperability required within hospital systems to optimize information flow but also discuss what can be achieved with the data collected. Very concrete and innovative examples within a fully interoperable care organization will be shared, including solutions for clinical alarm management, remote monitoring and surveillance, and data mobility. The dialogue will demonstrate how real time data sharing and integration in EMR systems - including mobility - supports better care coordination and patient management while promoting best practices and reducing health professionals’ stress."

"Many companies use disparate processes to meet calibration standards—ranging from pen-and-paper or spreadsheets to “smart” calibration devices and integrated software systems, or some combination of all of them. However, this task is too important and expensive to rely on outdated or disjointed processes. Join Nuvolo as we discuss how you can reduce the time it takes to perform a calibration while simultaneously delivering high-quality, actionable calibration data and fully compliant audit trails."

"At HIMSS, we constantly strive to push the healthcare industry forward. This requires us to continuously innovate our models to best reflect how to improve patient safety and the overall quality of clinical care. It has become increasingly crucial as we respond to the unique challenges of the pandemic.

Join us for a conversation with Philip Bradley, Digital Health Strategist at HIMSS to understand upcoming changes to HIMSS flagship model, EMRAM (Electronic Medical Record Adoption Model). The updated EMRAM 2022 will drive the industry forward with an outcomes-driven approach, identifying risks to health progress, mobilizing data to empower providers to proactively mitigate risk and expand digital capacity to ultimately strengthen organizational performance and health outcomes across patient populations."

"The webinar will explore some of the new requirements of SQF v9 that are proving problematic for some organizations that are upgrading their food safety programs in preparation for their first certification audits to the new standard.

Learning Objectives: Information on some of the issues experienced by organizations that have undergone certification audits to the SQF v9 standard, from the perspective of an experienced lead auditor that has performed a number of these assessments.

Who Should Attend: Organizations that are developing and implementing a food safety system and are anticipating their first SQF certification audit, or those organizations that are upgrading their existing certified food safety programs in preparation for their first certification audits to the new standard."

"As the prevalence of diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that will aid in the diagnosis and management of patients. This is a complex process that poses challenges for patients, physicians, hospitals and laboratories. What is changing in today’s world is that many hospitals are being asked to take steps toward improving proactive and preventive care, improving patient outcomes while also saving on healthcare costs associated with diabetes and diabetes complications. Laboratories are invaluable partners in addressing this challenge.

Join us to learn more about HbA1c assay methodologies, the impact of analytical quality, standardization and harmonization of testing, and the advantages of using a clinical chemistry test as a diagnostic tool to aid in improving a patient's glycaemic control, decrease long-term complications, and enhance overall patient care."

Capillary electrophoresis plays an important role in the diagnosis of hemoglobinopathy carriers and patients. The general flow is the determination of the red blood cell indices to establish a microcytic hypochromic anemia and Hb-typing by separation and quantitation of the different hemoglobin fractions. DNA analysis is the final confirming step to complete the diagnosis. In the era of Next Generation Sequencing, many genetic labs have employed Whole Exome Sequencing and Inherited Disease panels as tools to analyze DNA and detect disease causing mutation. However, functional assays are considered to be important to establish the function and effects of variants of uncertain significance. Functional assays in hemoglobinopathies are the hematology and the Hb-typing, either by capillary electrophoresis or HPLC, to be completed by DNA analysis as will be demonstrated during the talk."

"The second round of reporting for the Protecting Access to Medicare Act of 2014 (PAMA) is coming up January - March 2022 - are you ready?

The PAMA legislation has and will continue to significantly alter Medicare’s payment system for clinical laboratory testing while establishing significant new compliance demands. This legislation also has the potential to impact other payors’ rates, since many private payors base their reimbursement levels on Medicare rates.

Rhodes Group's consultants Denise Mazon and Doug Wussow are here to help you prepare for PAMA by answering your pressing questions, such as:

* How will the second round of cuts impact my lab revenue?
* How will PAMA cuts impact non-Medicare billings?
* How will these insights help my lab make better decisions on go forward strategy?"